Francis Patrick Ostronic - Nov 28, 2023 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Director
Signature
/s/ Patrick Ostronic
Stock symbol
CYTH
Transactions as of
Nov 28, 2023
Transactions value $
$0
Form type
4
Date filed
11/30/2023, 09:07 AM
Previous filing
Oct 23, 2023
Next filing
Feb 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTH Common Stock Award $0 +10.3K +3.22% $0.00 329K Nov 28, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee directorcompensation policy. Grant reflects director compensation for the third quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of $1.34per share of common stock on November 28, 2023.